Non categorizzato Novo Holdings to buy Catalent for $16.5B Febbraio 5, 2024 0 commenti Novo Holdings A/S, the holding company for pharmaceutical Novo Nordisk, announced on Monday that it is acquiring Catalent Inc. for $16.5 billion in cash at $63.50 per share, representing a 16.5% premi… About the author:
Get involved!
Comments